Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Natural History Study of Patients With Neurofibromatosis Type I

View source ↗

Summary

The National Cancer Institute is conducting an observational natural history study of patients with Neurofibromatosis Type 1. The study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis Type 1, Malignant Peripheral Nerve Sheath Tumor | Status: ACTIVE_NOT_RECRUITING